Across TCGA pan-cancer cohorts, BCRP7 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of BCRP7’s most consistent transcriptional readouts.
The strongest signal is observed in breast invasive carcinoma (BRCA), where BCRP7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BCRP7 is over-expressed in tumor.
BRCA, LUSC, and LUAD are the cancer types where BCRP7 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BCRP7 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.